Access to medicines is a major global public health issue. While developed countries benefit from generally high-performing healthcare systems and an abundant supply of medicines, the situation is very different in developing countries. The latter face numerous challenges that limit their populations’ access to essential medicines.

The main obstacles to accessing medicines in developing countries

Several factors underlie the difficulties populations in developing countries face in accessing essential medicines.

• Cost of medicines : High drug prices-particularly for innovative medicines—pose a major challenge for the healthcare budgets of developing countries.
• Healthcare infrastructure : A lack of adequate healthcare infrastructure, such as hospitals, pharmacies, and cold-chain facilities for temperature-sensitive medicines, complicates drug distribution.
• Availability of medicines : Stockouts are frequent, especially for essential medicines, due to logistical, regulatory, or production issues.
• Social inequalities : The poorest populations are often the most affected by a lack of access to medicines, owing to their limited purchasing power and distance from healthcare facilities.

Naturally, this has consequences at various levels.

The consequences of a lack of access to essential medicines

The consequences are varied.

• Increased morbidity and mortality : Many diseases—particularly infectious ones—cannot be effectively treated without access to appropriate medicines.
• An economic burden : Untreated illnesses can lead to complications and costly hospitalizations, driving up healthcare spending in the affected countries.
• Reduced productivity : Untreated illnesses can diminish individuals’ capacity to work, thereby hindering national economic development.

While solutions have been implemented and the issue remains a subject of debate, more work needs to be done. By improving access to medicines, developing countries can enhance the health of their populations and foster economic development.